Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,000,553 papers from all fields of science
Search
Sign In
Create Free Account
MK 0677
Known as:
MK 677
, MK-0677
, MK-677
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
ibutamoren mesylate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2008
Review
2008
Effects of an Oral Ghrelin Mimetic on Body Composition and Clinical Outcomes in Healthy Older Adults
R. Nass
,
S. Pezzoli
,
+7 authors
M. Thorner
Annals of Internal Medicine
2008
Corpus ID: 54351396
Context The age-related decline of growth hormone secretion may play a role in sarcopenia and frailty. Content In this randomized…
Expand
Highly Cited
2005
Highly Cited
2005
Nonpeptide and peptide growth hormone secretagogues act both as ghrelin receptor agonist and as positive or negative allosteric modulators of ghrelin signaling.
B. Holst
,
E. Brandt
,
A. Bach
,
A. Heding
,
T. Schwartz
Molecular Endocrinology
2005
Corpus ID: 10977222
Two nonpeptide (L692,429 and MK-677) and two peptide [GH-releasing peptide (GHRP)-6 and ghrelin] agonists were compared in…
Expand
Highly Cited
2004
Highly Cited
2004
The Effects of MK‐0677, an Oral Growth Hormone Secretagogue, in Patients with Hip Fracture
M. Bach
,
K. Rockwood
,
+14 authors
V. Fuh
Journal of The American Geriatrics Society
2004
Corpus ID: 41417140
Objectives: To evaluate the effects of MK‐0677, an orally active growth hormone (GH) secretagogue, on functional recovery from…
Expand
Highly Cited
1999
Highly Cited
1999
A New Orphan Receptor Involved in Pulsatile Growth Hormone Release
Roy G. Smith
,
S. Feighner
,
K. Prendergast
,
Xiaomin Guan
,
A. Howard
Trends in endocrinology and metabolism
1999
Corpus ID: 23168170
Highly Cited
1998
Highly Cited
1998
Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure.
J. Svensson
,
L. Lönn
,
+9 authors
B. Bengtsson
Journal of Clinical Endocrinology and Metabolism
1998
Corpus ID: 24790050
Obesity is associated with blunted GH secretion, unfavorable body composition, and increased cardiovascular mortality. The…
Expand
Highly Cited
1998
Highly Cited
1998
MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism.
M. Murphy
,
L. Plunkett
,
+4 authors
D. Clemmons
Journal of Clinical Endocrinology and Metabolism
1998
Corpus ID: 3831700
The reversal of diet-induced negative nitrogen balance by GH suggests a possible therapeutic role for GH treatment in catabolic…
Expand
1998
1998
Treatment with the Oral Growth Hormone Secretagogue MK‐677 Increases Markers of Bone Formation and Bone Resorption in Obese Young Males
J. Svensson
,
C. Ohlsson
,
+9 authors
B. Bengtsson
Journal of Bone and Mineral Research
1998
Corpus ID: 23649200
The effect of 2 months of treatment with the oral growth hormone (GH) secretagogue MK‐677 on markers of bone metabolism was…
Expand
Highly Cited
1998
Highly Cited
1998
Structural requirements for the activation of the human growth hormone secretagogue receptor by peptide and nonpeptide secretagogues.
S. Feighner
,
A. Howard
,
+12 authors
L. V. D. van der Ploeg
Molecular Endocrinology
1998
Corpus ID: 18693999
Highly Cited
1996
Highly Cited
1996
Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects.
I. Chapman
,
M. Bach
,
+11 authors
M. Thorner
Journal of Clinical Endocrinology and Metabolism
1996
Corpus ID: 28266893
Aging is associated with declining activity of the GH axis, possibly contributing to adverse body composition changes and…
Expand
Highly Cited
1996
Highly Cited
1996
Effects of a 7-day treatment with a novel, orally active, growth hormone (GH) secretagogue, MK-677, on 24-hour GH profiles, insulin-like growth factor I, and adrenocortical function in normal young…
G. Copinschi
,
A. Van Onderbergen
,
+7 authors
E. van Cauter
Journal of Clinical Endocrinology and Metabolism
1996
Corpus ID: 558245
To assess the effects of prolonged administration of a novel analog of GH-releasing peptide (MK-677), nine healthy young men…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE